Original Research
Published on 09 Dec 2025
CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy
in Clinical Infectious Diseases
- 807 views
Original Research
Published on 09 Dec 2025
in Clinical Infectious Diseases
Original Research
Published on 09 Dec 2025
in Clinical and Diagnostic Microbiology and Immunology
Perspective
Published on 09 Dec 2025
in Bacteria and Host
Original Research
Published on 09 Dec 2025
in Clinical Infectious Diseases
Original Research
Published on 09 Dec 2025
in Clinical Infectious Diseases
Original Research
Published on 09 Dec 2025
in Clinical Infectious Diseases
Original Research
Accepted on 08 Dec 2025
in Clinical Infectious Diseases
Original Research
Accepted on 08 Dec 2025
in Clinical Infectious Diseases
Perspective
Accepted on 08 Dec 2025
in Virus and Host
Review
Accepted on 08 Dec 2025
in Microbial Vaccines
Original Research
Accepted on 08 Dec 2025
in Bacteria and Host
Review
Accepted on 08 Dec 2025
in Bacteria and Host
Original Research
Accepted on 08 Dec 2025
in Clinical Infectious Diseases
Original Research
Accepted on 08 Dec 2025
in Clinical Infectious Diseases
Original Research
Accepted on 08 Dec 2025
in Clinical Infectious Diseases
Review
Accepted on 08 Dec 2025
in Intestinal Microbiome
Systematic Review
Accepted on 08 Dec 2025
in Extra-intestinal Microbiome
Original Research
Accepted on 08 Dec 2025
in Biofilms
Original Research
Accepted on 08 Dec 2025
in Antibiotic Resistance and New Antimicrobial drugs
Original Research
Accepted on 08 Dec 2025
in Molecular Bacterial Pathogenesis
Original Research
Accepted on 08 Dec 2025
in Virus and Host
Original Research
Accepted on 08 Dec 2025
in Bacteria and Host
Original Research
Published on 08 Dec 2025
in Antibiotic Resistance and New Antimicrobial drugs
Brief Research Report
Published on 08 Dec 2025
in Extra-intestinal Microbiome